{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:35:01Z","timestamp":1771670101075,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Colorectal cancer (CRC) is one of the most common cancers, with an annual incidence of ~135,000 in the US, associated with ~50,000 deaths. Autosomal dominant polycystic kidney disease (ADPKD), associated with mutations disabling the <jats:italic>PKD1<\/jats:italic> gene, affects as many as 1 in 1000. Intriguingly, some studies have suggested that individuals with germline mutations in <jats:italic>PKD1<\/jats:italic> have reduced incidence of CRC, suggesting a genetic modifier function. Using mouse models, we here establish that loss of <jats:italic>Pkd1<\/jats:italic> greatly reduces CRC incidence and tumor growth induced by loss of the tumor suppressor <jats:italic>Apc<\/jats:italic>. Growth of <jats:italic>Pkd1<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup><jats:italic>;Apc<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> organoids was reduced relative to <jats:italic>Apc<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> organoids, indicating a cancer cell-intrinsic activity, even though <jats:italic>Pkd1<\/jats:italic> loss enhanced activity of pro-oncogenic signaling pathways. Notably, <jats:italic>Pkd1<\/jats:italic> loss increased colon barrier function, with <jats:italic>Pkd1<\/jats:italic>-deficient animals resistant to DSS-induced colitis, associated with upregulation of claudins that decrease permeability, and reduced T cell infiltration. Notably, <jats:italic>Pkd1<\/jats:italic> loss caused greater sensitivity to activation of CFTR, a tumor suppressor in CRC, paralleling signaling relations in ADPKD. Overall, these data and other data suggest germline and somatic mutations in <jats:italic>PKD1<\/jats:italic> may influence incidence, presentation, and treatment response in human CRC and other pathologies involving the colon.<\/jats:p>","DOI":"10.1038\/s41389-023-00486-y","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T02:01:59Z","timestamp":1691200919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Loss of Pkd1 limits susceptibility to colitis and colorectal cancer"],"prefix":"10.1038","volume":"12","author":[{"given":"Anna S.","family":"Nikonova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Y.","family":"Deneka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flaviane N.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabnam","family":"Pirestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Tricarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna A.","family":"Kiseleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Flieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei I.","family":"Grivennikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-3673","authenticated-orcid":false,"given":"Erica A.","family":"Golemis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,5]]},"reference":[{"key":"486_CR1","unstructured":"American_Cancer_Society. Colorectal cancer facts and figures 2014\u20132016. Atlanta: American Cancer Society I; 2014."},{"key":"486_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759\u201367.","journal-title":"Cell"},{"key":"486_CR3","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1073\/pnas.0712345105","volume":"105","author":"S Jones","year":"2008","unstructured":"Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, Antal T, et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA. 2008;105:4283\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/path.4842","volume":"241","author":"MA Glaire","year":"2017","unstructured":"Glaire MA, Brown M, Church DN, Tomlinson I. Cancer predisposition syndromes: lessons for truly precision medicine. J Pathol. 2017;241:226\u201335.","journal-title":"J Pathol"},{"key":"486_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543:65\u201371.","journal-title":"Nature"},{"key":"486_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pathol.2017.09.004","volume":"50","author":"H Ma","year":"2018","unstructured":"Ma H, Brosens LAA, Offerhaus GJA, Giardiello FM, de Leng WWJ, Montgomery EA. Pathology and genetics of hereditary colorectal cancer. Pathology. 2018;50:49\u201359.","journal-title":"Pathology"},{"key":"486_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41588-018-0286-6","volume":"51","author":"JR Huyghe","year":"2019","unstructured":"Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019;51:76\u201387.","journal-title":"Nat Genet"},{"key":"486_CR8","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1681\/ASN.2013101122","volume":"25","author":"JB Wetmore","year":"2014","unstructured":"Wetmore JB, Calvet JP, Yu AS, Lynch CF, Wang CJ, Kasiske BL, et al. Polycystic kidney disease and cancer after renal transplantation. J Am Soc Nephrol. 2014;25:2335\u201341.","journal-title":"J Am Soc Nephrol"},{"key":"486_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2017050483","volume":"29","author":"E Cornec-Le Gall","year":"2018","unstructured":"Cornec-Le Gall E, Torres VE, Harris PC. Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J Am Soc Nephrol. 2018;29:13\u201323.","journal-title":"J Am Soc Nephrol"},{"key":"486_CR10","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1681\/ASN.2015050583","volume":"27","author":"CM Heyer","year":"2016","unstructured":"Heyer CM, Sundsbak JL, Abebe KZ, Chapman AB, Torres VE, Grantham JJ, et al. Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27:2872\u201384.","journal-title":"J Am Soc Nephrol"},{"key":"486_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-011-0950-8","volume":"129","author":"CJ Ward","year":"2011","unstructured":"Ward CJ, Wu Y, Johnson RA, Woollard JR, Bergstralh EJ, Cicek MS, et al. Germline PKHD1 mutations are protective against colorectal cancer. Hum Genet. 2011;129:345\u20139.","journal-title":"Hum Genet"},{"key":"486_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393:919\u201335.","journal-title":"Lancet"},{"key":"486_CR13","first-page":"F451","volume":"272","author":"L Geng","year":"1997","unstructured":"Geng L, Segal Y, Pavlova A, Barros EJ, Lohning C, Lu W, et al. Distribution and developmentally regulated expression of murine polycystin. Am J Physiol. 1997;272:F451\u2013459.","journal-title":"Am J Physiol"},{"key":"486_CR14","first-page":"230","volume":"28","author":"SE Conduit","year":"2019","unstructured":"Conduit SE, Hakim S, Feeney SJ, Ooms LM, Dyson JM, Abud HE, et al. Beta-catenin ablation exacerbates polycystic kidney disease progression. Hum Mol Genet. 2019;28:230\u201344.","journal-title":"Hum Mol Genet"},{"key":"486_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2011.87","volume":"80","author":"A Wuebken","year":"2011","unstructured":"Wuebken A, Schmidt-Ott KM. WNT\/beta-catenin signaling in polycystic kidney disease. Kidney Int. 2011;80:135\u20138.","journal-title":"Kidney Int"},{"key":"486_CR16","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/ijc.29140","volume":"136","author":"AN Gargalionis","year":"2015","unstructured":"Gargalionis AN, Korkolopoulou P, Farmaki E, Piperi C, Dalagiorgou G, Adamopoulos C, et al. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer. Int J Cancer. 2015;136:1515\u201327.","journal-title":"Int J Cancer"},{"key":"486_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.celrep.2014.03.064","volume":"7","author":"P Outeda","year":"2014","unstructured":"Outeda P, Huso DL, Fisher SA, Halushka MK, Kim H, Qian F, et al. Polycystin signaling is required for directed endothelial cell migration and lymphatic development. Cell reports. 2014;7:634\u201344.","journal-title":"Cell reports"},{"key":"486_CR18","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/nm1675","volume":"13","author":"K Piontek","year":"2007","unstructured":"Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med. 2007;13:1490\u20135.","journal-title":"Nat Med"},{"key":"486_CR19","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1097\/01.ASN.0000144204.01352.86","volume":"15","author":"KB Piontek","year":"2004","unstructured":"Piontek KB, Huso DL, Grinberg A, Liu L, Bedja D, Zhao H, et al. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J Am Soc Nephrol. 2004;15:3035\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"486_CR20","doi-asserted-by":"publisher","first-page":"12859","DOI":"10.1073\/pnas.1405362111","volume":"111","author":"AS Nikonova","year":"2014","unstructured":"Nikonova AS, Plotnikova OV, Serzhanova V, Efimov A, Bogush I, Cai KQ, et al. Nedd9 restrains renal cystogenesis in Pkd1-\/- mice. Proc Natl Acad Sci USA. 2014;111:12859\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR21","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1096\/fj.201700909R","volume":"32","author":"AS Nikonova","year":"2018","unstructured":"Nikonova AS, Deneka AY, Kiseleva AA, Korobeynikov V, Gaponova A, Serebriiskii IG, et al. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD). FASEB J. 2018;32:2735\u201346.","journal-title":"FASEB J"},{"key":"486_CR22","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.1073\/pnas.1301904110","volume":"110","author":"T Seeger-Nukpezah","year":"2013","unstructured":"Seeger-Nukpezah T, Proia DA, Egleston BL, Nikonova AS, Kent T, Cai KQ, et al. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease. Proc Natl Acad Sci USA. 2013;110:12786\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature11465","volume":"491","author":"SI Grivennikov","year":"2012","unstructured":"Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, et al. Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth. Nature. 2012;491:254\u20138.","journal-title":"Nature"},{"key":"486_CR24","doi-asserted-by":"publisher","first-page":"44608","DOI":"10.1074\/jbc.M307435200","volume":"278","author":"T Hinoi","year":"2003","unstructured":"Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem. 2003;278:44608\u201316.","journal-title":"J Biol Chem"},{"key":"486_CR25","doi-asserted-by":"publisher","first-page":"9721","DOI":"10.1158\/0008-5472.CAN-07-2735","volume":"67","author":"T Hinoi","year":"2007","unstructured":"Hinoi T, Akyol A, Theisen BK, Ferguson DO, Greenson JK, Williams BO, et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res. 2007;67:9721\u201330.","journal-title":"Cancer Res"},{"key":"486_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1182\/blood.V75.3.611.611","volume":"75","author":"LG Billips","year":"1990","unstructured":"Billips LG, Petitte D, Landreth KS. Bone marrow stromal cell regulation of B lymphopoiesis: interleukin-1 (IL-1) and IL-4 regulate stromal cell support of pre-B cell production in vitro. Blood. 1990;75:611\u20139.","journal-title":"Blood"},{"key":"486_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160:324\u201338.","journal-title":"Cell"},{"key":"486_CR28","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1158\/0008-5472.CAN-20-3626","volume":"81","author":"AY Deneka","year":"2021","unstructured":"Deneka AY, Kopp MC, Nikonova AS, Gaponova AV, Kiseleva AA, Hensley HH, et al. Nedd9 restrains autophagy to limit growth of early stage non-small cell lung cancer. Cancer Res. 2021;81:3717\u201326.","journal-title":"Cancer Res"},{"key":"486_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1046-2023(03)00032-X","volume":"30","author":"J Debnath","year":"2003","unstructured":"Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30:256\u201368.","journal-title":"Methods"},{"key":"486_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","volume":"25","author":"C Trapnell","year":"2009","unstructured":"Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25:1105\u201311.","journal-title":"Bioinformatics"},{"key":"486_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511\u20135.","journal-title":"Nat Biotechnol"},{"key":"486_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nbt.2450","volume":"31","author":"C Trapnell","year":"2013","unstructured":"Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 2013;31:46\u201353.","journal-title":"Nat Biotechnol"},{"key":"486_CR33","doi-asserted-by":"publisher","first-page":"8936.","DOI":"10.3390\/ijms21238936","volume":"21","author":"M Fragiadaki","year":"2020","unstructured":"Fragiadaki M, Macleod FM, Ong ACM. The controversial role of fibrosis in autosomal dominant polycystic kidney disease. Int J Mol Sci. 2020;21:8936.","journal-title":"Int J Mol Sci"},{"key":"486_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","volume":"111","author":"M van de Wetering","year":"2002","unstructured":"van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, et al. The beta-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111:241\u201350.","journal-title":"Cell"},{"key":"486_CR35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/onc.2011.294","volume":"31","author":"G Zhu","year":"2012","unstructured":"Zhu G, Wang Y, Huang B, Liang J, Ding Y, Xu A, et al. A Rac1\/PAK1 cascade controls beta-catenin activation in colon cancer cells. Oncogene. 2012;31:1001\u201312.","journal-title":"Oncogene"},{"key":"486_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","volume":"15","author":"JJ Grantham","year":"1990","unstructured":"Grantham JJ. Polycystic kidney disease: neoplasia in disguise. Am J Kidney Dis. 1990;15:110\u20136.","journal-title":"Am J Kidney Dis"},{"key":"486_CR37","unstructured":"Grantham JJ, Nair V, Winklhoffer F. Cystic diseases of the kidney. In: Brenner BM, editors. Brenner & rector\u2019s the kidney. Philadelphia: WB Saunders Company; 2000. p. 1699\u2013730."},{"key":"486_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrgastro.2017.1","volume":"14","author":"CR Choi","year":"2017","unstructured":"Choi CR, Bakir IA, Hart AL, Graham TA. Clonal evolution of colorectal cancer in IBD. Nat Rev Gastroenterol Hepatol. 2017;14:218\u201329.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"486_CR39","doi-asserted-by":"publisher","first-page":"18456","DOI":"10.18632\/oncotarget.14472","volume":"8","author":"N Gonzalez","year":"2017","unstructured":"Gonzalez N, Prieto I, Del Puerto-Nevado L, Portal-Nunez S, Ardura JA, Corton M, et al. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget. 2017;8:18456\u201385.","journal-title":"Oncotarget"},{"key":"486_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer-mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10:455\u201365.","journal-title":"Nat Rev Endocrinol"},{"key":"486_CR41","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s13277-013-0876-y","volume":"34","author":"S Rasool","year":"2013","unstructured":"Rasool S, Kadla SA, Rasool V, Ganai BA. A comparative overview of general risk factors associated with the incidence of colorectal cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2013;34:2469\u201376.","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"486_CR42","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.immuni.2014.11.009","volume":"41","author":"K Wang","year":"2014","unstructured":"Wang K, Kim MK, Di Caro G, Wong J, Shalapour S, Wan J, et al. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity. 2014;41:1052\u201363.","journal-title":"Immunity"},{"key":"486_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14228","volume":"519","author":"K Taniguchi","year":"2015","unstructured":"Taniguchi K, Wu LW, Grivennikov SI, de Jong PR, Lian I, Yu FX, et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature. 2015;519:57\u201362.","journal-title":"Nature"},{"key":"486_CR44","first-page":"2516","volume":"118","author":"LB Meira","year":"2008","unstructured":"Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest. 2008;118:2516\u201325.","journal-title":"J Clin Invest"},{"key":"486_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/carcin\/bgi205","volume":"27","author":"R Suzuki","year":"2006","unstructured":"Suzuki R, Kohno H, Sugie S, Nakagama H, Tanaka T. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis. 2006;27:162\u20139.","journal-title":"Carcinogenesis"},{"key":"486_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1152\/physrev.00019.2012","volume":"93","author":"D Gunzel","year":"2013","unstructured":"Gunzel D, Yu AS. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93:525\u201369.","journal-title":"Physiol Rev"},{"key":"486_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/path.2392","volume":"216","author":"AS Yu","year":"2008","unstructured":"Yu AS, Kanzawa SA, Usorov A, Lantinga-van Leeuwen IS, Peters DJ. Tight junction composition is altered in the epithelium of polycystic kidneys. J Pathol. 2008;216:120\u20138.","journal-title":"J Pathol"},{"key":"486_CR48","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1136\/gutjnl-2014-308419","volume":"64","author":"H Tanaka","year":"2015","unstructured":"Tanaka H, Takechi M, Kiyonari H, Shioi G, Tamura A, Tsukita S. Intestinal deletion of Claudin-7 enhances paracellular organic solute flux and initiates colonic inflammation in mice. Gut. 2015;64:1529\u201338.","journal-title":"Gut"},{"key":"486_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000095133","volume":"18","author":"M Ikeda","year":"2006","unstructured":"Ikeda M, Fong P, Cheng J, Boletta A, Qian F, Zhang XM, et al. A regulatory role of polycystin-1 on cystic fibrosis transmembrane conductance regulator plasma membrane expression. Cell Physiol Biochem. 2006;18:9\u201320.","journal-title":"Cell Physiol Biochem"},{"key":"486_CR50","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1038\/onc.2015.483","volume":"35","author":"BL Than","year":"2016","unstructured":"Than BL, Linnekamp JF, Starr TK, Largaespada DA, Rod A, Zhang Y, et al. CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene. 2016;35:4179\u201387.","journal-title":"Oncogene"},{"key":"486_CR51","doi-asserted-by":"publisher","first-page":"2891.","DOI":"10.3390\/ijms21082891","volume":"21","author":"P Scott","year":"2020","unstructured":"Scott P, Anderson K, Singhania M, Cormier R. Cystic fibrosis, CFTR, and colorectal cancer. Int J Mol Sci. 2020;21:2891.","journal-title":"Int J Mol Sci"},{"key":"486_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00441-013-1734-3","volume":"355","author":"De Lisle RC","year":"2014","unstructured":"De Lisle RC. Disrupted tight junctions in the small intestine of cystic fibrosis mice. Cell Tissue Res. 2014;355:131\u201342.","journal-title":"Cell Tissue Res"},{"key":"486_CR53","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s40265-016-0611-2","volume":"76","author":"ED Deeks","year":"2016","unstructured":"Deeks ED. Lumacaftor\/ivacaftor: a review in cystic fibrosis. Drugs. 2016;76:1191\u2013201.","journal-title":"Drugs"},{"key":"486_CR54","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ebiom.2015.10.010","volume":"2","author":"Y Osawa","year":"2015","unstructured":"Osawa Y, Oboki K, Imamura J, Kojika E, Hayashi Y, Hishima T, et al. Inhibition of cyclic adenosine monophosphate (cAMP)-response element-binding protein (CREB)-binding protein (CBP)\/beta-catenin reduces liver fibrosis in mice. EBioMedicine. 2015;2:1751\u20138.","journal-title":"EBioMedicine"},{"key":"486_CR55","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJM200009283431302","volume":"343","author":"LB Saltz","year":"2000","unstructured":"Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;343:905\u201314.","journal-title":"N Engl J Med"},{"key":"486_CR56","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrneph.2015.46","volume":"11","author":"T Seeger-Nukpezah","year":"2015","unstructured":"Seeger-Nukpezah T, Geynisman DM, Nikonova AS, Benzing T, Golemis EA. The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease. Nat Rev Nephrol. 2015;11:515\u201334.","journal-title":"Nat Rev Nephrol"},{"key":"486_CR57","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3748\/wjg.v25.i5.584","volume":"25","author":"C Xu","year":"2019","unstructured":"Xu C, Wang K, Ding YH, Li WJ, Ding L. Claudin-7 gene knockout causes destruction of intestinal structure and animal death in mice. World J Gastroenterol. 2019;25:584\u201399.","journal-title":"World J Gastroenterol"},{"key":"486_CR58","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3389\/fimmu.2019.01441","volume":"10","author":"L Zhu","year":"2019","unstructured":"Zhu L, Han J, Li L, Wang Y, Li Y, Zhang S. Claudin family participates in the pathogenesis of inflammatory Bowel diseases and colitis-associated colorectal cancer. Front Immunol. 2019;10:1441.","journal-title":"Front Immunol"},{"key":"486_CR59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-4939-3661-8_14","volume":"1438","author":"AJ Snider","year":"2016","unstructured":"Snider AJ, Bialkowska AB, Ghaleb AM, Yang VW, Obeid LM, Hannun YA. Murine model for colitis-associated cancer of the colon. Methods Mol Biol. 2016;1438:245\u201354.","journal-title":"Methods Mol Biol"},{"key":"486_CR60","doi-asserted-by":"publisher","first-page":"109630","DOI":"10.1016\/j.cellsig.2020.109630","volume":"72","author":"J Hu","year":"2020","unstructured":"Hu J, Harris PC. Regulation of polycystin expression, maturation and trafficking. Cell Signal. 2020;72:109630.","journal-title":"Cell Signal"},{"key":"486_CR61","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00018-012-1052-z","volume":"70","author":"J Pan","year":"2012","unstructured":"Pan J, Seeger-Nukpezah T, Golemis EA. The role of the cilium in normal and abnormal cell cycles: emphasis on renal cystic pathologies. Cell Mol Life Sci. 2012;70:1849\u201374.","journal-title":"Cell Mol Life Sci"},{"key":"486_CR62","doi-asserted-by":"publisher","first-page":"e55687","DOI":"10.15252\/embr.202255687","volume":"23","author":"C Paul","year":"2022","unstructured":"Paul C, Tang R, Longobardi C, Lattanzio R, Eguether T, Turali H, et al. Loss of primary cilia promotes inflammation and carcinogenesis. EMBO Rep. 2022;23:e55687.","journal-title":"EMBO Rep"},{"key":"486_CR63","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.15252\/embj.201488466","volume":"33","author":"C Rocha","year":"2014","unstructured":"Rocha C, Papon L, Cacheux W, Marques Sousa P, Lascano V, Tort O, et al. Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon. EMBO J. 2014;33:2247\u201360.","journal-title":"EMBO J"},{"key":"486_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1042\/BST20160142","volume":"45","author":"V Korobeynikov","year":"2017","unstructured":"Korobeynikov V, Deneka AY, Golemis EA. Mechanisms for nonmitotic activation of Aurora-A at cilia. Biochem Soc Trans. 2017;45:37\u201349.","journal-title":"Biochem Soc Trans"},{"key":"486_CR65","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1093\/hmg\/ddn208","volume":"17","author":"M Lal","year":"2008","unstructured":"Lal M, Song X, Pluznick JL, Di Giovanni V, Merrick DM, Rosenblum ND, et al. Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Hum Mol Genet. 2008;17:3105\u201317.","journal-title":"Hum Mol Genet"},{"key":"486_CR66","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1111\/jcmm.14506","volume":"23","author":"KA Papavassiliou","year":"2019","unstructured":"Papavassiliou KA, Zoi I, Gargalionis AN, Koutsilieris M. Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines. J Cell Mol Med. 2019;23:6215\u201327.","journal-title":"J Cell Mol Med"},{"key":"486_CR67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/path.2856","volume":"224","author":"H Happe","year":"2011","unstructured":"Happe H, van der Wal AM, Leonhard WN, Kunnen SJ, Breuning MH, de Heer E, et al. Altered Hippo signalling in polycystic kidney disease. J Pathol. 2011;224:133\u201342.","journal-title":"J Pathol"},{"key":"486_CR68","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1681\/ASN.2010010127","volume":"21","author":"A Luyten","year":"2010","unstructured":"Luyten A, Su X, Gondela S, Chen Y, Rompani S, Takakura A, et al. Aberrant regulation of planar cell polarity in polycystic kidney disease. J Am Soc Nephrol. 2010;21:1521\u201332.","journal-title":"J Am Soc Nephrol"},{"key":"486_CR69","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246\u201357.","journal-title":"Nat Rev Cancer"},{"key":"486_CR70","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"486_CR71","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-19-0899","volume":"25","author":"CH Lieu","year":"2019","unstructured":"Lieu CH, Golemis EA, Serebriiskii IG, Newberg J, Hemmerich A, Connelly C, et al. Comprehensive genomic landscapes in early and later onset colorectal cancer. Clin Cancer Res. 2019;25:5852\u20138.","journal-title":"Clin Cancer Res"},{"key":"486_CR72","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1681\/ASN.2018050493","volume":"29","author":"MB Lanktree","year":"2018","unstructured":"Lanktree MB, Haghighi A, Guiard E, Iliuta IA, Song X, Harris PC, et al. Prevalence estimates of polycystic kidney and liver disease by population sequencing. J Am Soc Nephrol. 2018;29:2593\u2013600.","journal-title":"J Am Soc Nephrol"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-023-00486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-023-00486-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-023-00486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T13:06:18Z","timestamp":1700399178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-023-00486-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,5]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["486"],"URL":"https:\/\/doi.org\/10.1038\/s41389-023-00486-y","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,5]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}